AGN's Principal Activity is the research and development of a neuroprotective therapeutic drug.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | +148.55% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Argenica Therapeutics Limited (AGN) is into research and development of a neuroprotective therapeutic drug. The Company is developing novel neuroprotective therapeutics to reduce brain damage after stroke.
No incorporation details available.
Head Office | Nedlands WA 6009 |
Website | www.argenica.com.au |
Registry | Link Market Services |
Auditor | RSM Australia Partners |
Date Listed | 11 Jun 2021 |
Date | Event |
---|---|
26/08/2022 | Report (Prelim) |
26/08/2022 | Report (Annual) |
21/02/2023 | Report (Interim) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
AGN directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of AGN directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
University of Western Australia | 25/08/2021 | 3,953,000 | 5.40 |
Geoffrey Pocock | 25/08/2021 | 4,377,000 | 5.98 |
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.20 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.